These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19654588)

  • 1. Brain-targeting mechanisms of lactoferrin-modified DNA-loaded nanoparticles.
    Huang R; Ke W; Han L; Liu Y; Shao K; Ye L; Lou J; Jiang C; Pei Y
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1914-23. PubMed ID: 19654588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
    Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.
    Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo.
    Huang R; Ke W; Han L; Liu Y; Shao K; Jiang C; Pei Y
    Brain Res Bull; 2010 Apr; 81(6):600-4. PubMed ID: 20026388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
    Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q
    Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.
    Huang R; Ke W; Liu Y; Jiang C; Pei Y
    Biomaterials; 2008 Jan; 29(2):238-46. PubMed ID: 17935779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain.
    Huang RQ; Ke WL; Qu YH; Zhu JH; Pei YY; Jiang C
    J Biomed Sci; 2007 Jan; 14(1):121-8. PubMed ID: 17048089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles.
    Huang R; Han L; Li J; Ren F; Ke W; Jiang C; Pei Y
    J Gene Med; 2009 Sep; 11(9):754-63. PubMed ID: 19554623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
    Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
    Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
    Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration.
    Huang R; Ke W; Han L; Li J; Liu S; Jiang C
    Biomaterials; 2011 Mar; 32(9):2399-406. PubMed ID: 21185076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis.
    Liu C; Yu W; Chen Z; Zhang J; Zhang N
    J Control Release; 2011 Apr; 151(2):162-75. PubMed ID: 21376765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
    Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
    Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of nanoparticles to the clathrin-mediated endocytic pathway.
    Harush-Frenkel O; Debotton N; Benita S; Altschuler Y
    Biochem Biophys Res Commun; 2007 Feb; 353(1):26-32. PubMed ID: 17184736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
    Hu K; Shi Y; Jiang W; Han J; Huang S; Jiang X
    Int J Pharm; 2011 Aug; 415(1-2):273-83. PubMed ID: 21651967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
    Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
    Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.
    Jallouli Y; Paillard A; Chang J; Sevin E; Betbeder D
    Int J Pharm; 2007 Nov; 344(1-2):103-9. PubMed ID: 17651930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced gene transfer into brain capillary endothelial cells using Antp-modified DNA-loaded nanoparticles.
    Huang RQ; Pei YY; Jiang C
    J Biomed Sci; 2007 Sep; 14(5):595-605. PubMed ID: 17447157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.